Can transcranial ultrasound and microbubble therapy ever enter the mainstream in acute stroke therapy?

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

TR Porter has received grant support from Lantheus Medical Imaging and NuvOx Pharma Inc.; equipment support from Philips Medical Solution; and is a consultant for Lantheus Medical Imaging. This work was supported in part by a grant from Philips Research North America, by the Theodore Hubbard Foundation (Omaha, NE, USA) and by grant R01 EB009050-03 from the National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD, USA). Additional instrumentation support was provided by Philips Health Care. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.